Connecting with Connected Health (PCHA Connected Health Conference)

December 20, 2016 | by

[grow_thumb image=”https://telecareaware.com/wp-content/uploads/2016/12/JC-with-VGo.jpg” thumb_width=”150″ /]Guest contributor JC Muyl attended the PCHA Connected Health Conference last week and contributed his thoughts on the event.

Last week I drove down from NYC to spend an afternoon at the Connected Health Conference (#CHC16) at the Gaylord Convention Center outside DC. The majority of my time was spent in the exhibit hall meeting digital health vendors.

I walked away fascinated by just how eclectic the digital health industry is. By approaching it from so many different angles, we’re bound to find some solutions that will stick. I thought I’d spread my optimism by sharing a sample of what I saw for those who couldn’t make it. Here’s my take on my day:

  • The most represented category was patient engagement solutions, probably as a function of the conference itself. Also, when you think about it, a proliferation of proactive patient engagement solutions makes sense in the context of value-based payments. What I like about patient engagement is that it has applications across multiple segments (payers, providers, employers, etc.) which means a bigger market. I met with the folks at Fitango Health (customizable care plans & member engagement), CareWire (member engagement via text), PokitDok (a development platform for care management / patient engagement), Utila (a text-based behavior health engagement solution) and Dacadoo (a cool health score app for patients based on proprietary algorithms).
  • Dacadoo was the play that felt most natively consumer-centric, especially because the user is able to track their health score in the app. The other solutions were for providers looking to manage and interact with patient populations. I like the notion of designing these products from the standpoint of how consumers want to navigate their healthcare experience.
  • In telehealth, I visited SwyMed, a ruggedized telehealth kit for emergency workers (makes a lot of sense), and VGo (see left above), a friendly-looking telehealth assistant that combined a Segway with a camera and a screen. They demoed how they could remotely drive it to the patient for a telehealth consult. I really think this product has legs…well wheels, actually! Seriously, it made me wonder how soon until we use drones to deliver meds & pick up samples?
  • I was surprised by the number of international companies: Medelinked from the UK, EarlySense from Israel, Voluntis from France, Dacadoo from Switzerland, most with a local presence here in the US. These foreign companies are usually pretty big in their home country, with a (clinically) proven product, yet are approaching the US market with the agility but also possibly the financial needs of a startup. I bet they would make good prospects for investors.

(more…)

Scanadu gets the #SCAMadu Rage of the Crowd, misses XPRIZE finals, raises $6.5 million

December 16, 2016 | by

[grow_thumb image=”https://telecareaware.com/wp-content/uploads/2015/04/Scanadu-Scout.jpg” thumb_width=”150″ /]UPDATED December has been a mense horribilis for Scanadu, what with bricking the Scanadu Scout next year, missing the Qualcomm XPRIZE finals and a low equity raise.

Scanadu Scout heading to Doorstop and Paperweight-ville. This all-in-one diagnostic device, which promoted itself as a tricorder worthy of Star Trek‘s Bones, announced on 13 December that on 15 May next year, it will deactivate all units. (What Bones would say: “It’s dead, Jim!”) Users of this admittedly investigational device who purchased it for $200 starting in 2014, glitches and all, [TTA 5 Apr 14], are facing not only that it will ‘cease to function’ but also presumably the loss of access to their data as well. A Scanadu spokesperson to TechCrunch last week (13 Dec) attributed the action as necessary to comply with FDA regulations requiring investigational use devices to be deactivated at the end of the study.

Scanadu also failed to make the Qualcomm Tricorder XPRIZE Final Two, also announced on the same day. They had already teamed with Intelesens of Northern Ireland. (More below)

Mobihealthnews reported on Sunday 18 December that Scanadu completed an additional $6.5 million equity funding, according to a SEC filing. Investors are not disclosed. The funding dated 7 December is considerably less than their $35 million Series B raise, primarily from Chinese VC investors, back in April 2015 which is the bulk of their now $56.1 million funding to date (CrunchBase). It is hard to interpret this one way or another, but MHN’s Jonah Comstock doesn’t hesitate to relate it to both the Scout bricking and the XPRIZE loss. To this Editor, it’s either conservative or like a line of credit, but why now, and not what you expect after a healthy Series B.

Returning to the soon-to-be bricked Scouts, there is no mention of current customer compensation, swap or discounting on future purchases of other Scanadu products, such as Vitals, the successor to the Scout, or Urine for urine testing. (more…)

Peak flow in your pocket: Smart Peak Flow meter/app gets Kickstarted (UK)

December 16, 2016 | by
[grow_thumb image=”https://telecareaware.com/wp-content/uploads/2016/12/smartflow-meter.png” thumb_width=”150″ /]A UK-based startup, Smart Respiratory Products, has successfully Kickstarted its smartphone/tablet-based peak flow meter and app with a total pledge to date of £11,322 (just over $14,000). Targeted to asthmatics, the meter plugs into the 3.5 mm audio jack (left). Like a standard peak flow meter, the user blows into the Smart Peak Flow meter, and the measurement is sent to the app, available through the Apple Store and Google Play. The measurement must be taken in a well-lit area, as the ambient light is chopped up by a photo sensor at the bottom as the patient’s forceful breath passes through a fan. The flashing signal goes into the microphone as a sound file.

The app measures the force of breath and charts it. It also engages the user through challenges, “personal bests” and winning streaks. There are also virtual badges awarded and snappy ‘earned quotes’. Those who take the ’90 Day Challenge’ of daily use receive an inhaler monitor, a cap that transmits to the phone when the inhaler is used.

Smart does not mention other respiratory uses for the peak flow meter, such as COPD.

According to MedCityNews, the company plans to complete its 510(k) and CE Mark applications by mid-2017. They will ship IFU prototypes to its Kickstarter supporters in February. The pricing on Kickstarter for the device is £10 with deluxe versions starting at £16. MedCityNews also noted that Sparo Labs’ Wing, which we profiled in November 2015, gained its FDA clearance in June but is at a $129 price. Founder Thomas Antalffy of Smart:  “I have spoken to pharmaceutical companies, and the dream for me would be to include Smart Peak Flow or the smart inhaler with every box of inhalers people buy.” At his prices, it might be possible.

NHS Scotland launches Attend Anywhere video consult trial

December 14, 2016 | by
[grow_thumb image=”https://telecareaware.com/wp-content/uploads/2016/12/VC_Infographics_WaitingAreaOverview01_600pxwide.png” thumb_width=”200″ /]Announced earlier this month by Shona Robison, Cabinet Secretary for Health and Sport, Scottish Government at the Scottish Digital Health & Care Week and Conference is the pilot of the Attend Anywhere virtual doctor visits. The consults are through a patient’s computer, smartphone or tablet using a Google Chrome web browser. The patient logs in to the website, waits in a private video room, the provider is notified that the patient is in the queue, and when the doctor is available, the video visit will start. (See illustration at left)

Initially, the service will target video call access to up to 50 health care providers including primary care, specialist services, speech and language therapy as well as pharmacy prescription reviews. According to Attend Anywhere, the service is available now to Scots in both rural and metropolitan areas. The service was developed as part of a collaboration between NHS Scotland’s Technology Enabled Care (TEC) Programme, Melbourne Australia-based video consulting specialists Attend Anywhere, and Healthdirect Australia, supported by NHS 24 Scottish Centre for Telehealth and Telecare. The press release links to a video of the consults in use in western New South Wales, including a care home. Scottish Centre demonstration site, Scottish Digital Health Week page.  Hat tip to Chris Ryan of Attend Anywhere Australia for the original articles and corrections. His LinkedIn post here shows the Scottish Centre’s table at the conference.

WLSA merger with PCHAlliance: the digital health conference scene contracts a bit more

December 12, 2016 | by

Over the weekend, the Personal Connected Health Alliance (PCHAlliance) and the Wireless-Life Sciences Alliance (WLSA) announced that the San Diego-based WLSA would be combining its operations with the PCHAlliance. This follows on the earlier announcement [TTA 21 Oct] that the Boston-based and Partners HealthCare- owned Connected Health Symposium would be folding its operation into the PCHAlliance. Both Robert B. McCray, co-founder and CEO of WLSA, and Dr Joseph Kvedar of Partners HealthCare are now Senior Advisers to the PCHAlliance, with Mr McCraw heading Thought Leadership and Dr Kvedar now Program Chair of next year’s event.

WLSA has been largely inactive on the conference scene since 2015, when it staged its last Convergence Summit in May and the Wireless Health event in October of that year. The Convergence Summit has been merged into PCHAlliance’s Connected Health Conference kicking off today near Washington, DC. The Wireless Health event will continue through a collaboration with IEEE/EMBS cooperating with the National Institutes of Health (NIH) and the National Science Foundation (NSF).

In their release, PCHAlliance emphasized WLSA’s experience in research within engineering, computer science, biomedical and health disciplines. Patricia (Patty) Mechael, PhD, Executive Vice President, PCHAlliance in the release was quoted that “Their focus on medical and health research communities is a perfect compliment to our commitment to accelerate the adoption of clinical grade technology in consumer-friendly health outcomes- based business models.” Life science companies will be welcomed for membership in the PCHAlliance. PCHAlliance also includes Continua, which for well over a decade has been promoting engineering standards for device interoperability.

As this Editor looked back in October, when most of these organizations and events started about 2007-8, there were few Big Health conferences that took what was then dubbed eHealth and mHealth (later Digital Health) seriously. Now, of course, they do. There are also multiple events, large and small, expensive and popularly priced, every month in many cities–we attended and reported on #MedMo16 which will be branching out to multiple cities in 2017.

In looking back at our articles, the WLSA was engaged with the conference almost from the start, when the mHealth Summitwas one of the first ‘big name/big support’ conferences. Its tack then was governmental policy and what international NGOs were doing as a model for developed nations. It was organized by the Foundation for the National Institutes of Health, the National Institutes of Health and the mHealth Alliance up to 2012, when HIMSS took it over.

Grizzled Pioneers, and even the non-grizzled, can testify to the multiple phases in a decade up and down the Hype Curve: device-driven, mobile-driven, sensor-driven, telehealth, wearables, Big Data, population health, patient engagement, analytics, data integration, outcomes-based and a few others. This move confirms that many factors are blending: academic, engineering, software, biotech, genomics, social, behavioral, governmental–and that technology is not standalone or sitting in isolation, but is integrating and manifesting itself in all sorts of interesting places both behind the consumer scene and in policy, and to consumers on mobiles and in the home (IoT, which hasn’t resolved its multiple and obvious security problems).

Also Neil Versel in MedCityNews. TTA is a media partner of the PCHA CHC for the 8th year, starting in 2009 when it was the brand new mHealth Summit. Conference tweets on #connect2health.

Patients as People: creating clinically relevant social insights (part II)

December 12, 2016 | by

Guest Editor Sarianne Gruber (@subtleimpact) continues her interview of Mandi Bishop, founder and Chief Evangelist of Aloha Health. Ms Bishop’s goal with Aloha Health is to put the ‘patient as person’ into the present healthcare model. Ms Gruber interviewed Ms Bishop at #MedMo16 where Aloha Health won the People’s Choice award in the Equity Crowd Challenge. The first half of the interview was previously published in Part I.

How does Social Determinants Of Healthcare (SDOH) data relate to me as a patient?

Bishop: SDOH attributes are available both the individual patient level and a “high propensity that this is you” level via micro-segmentation. Optimally, there will be personalization of information where personalization is possible and micro-segmentation profiles for when it is not.  Also, we are not trying to give the doctor more data since we think that is a big part of the problem.  “What about your lifestyle” matters which respect to you as a patient, and we at Aloha Health convert that data into insights.  When the doctor pulls up an encounter, based on our models, the EHR is populated with the insights that are available about you and your conditions.

As a workflow example, I pull up your encounter.  Aloha then pings the Aloha insights section and gets all this information about you. This is the use case we are going after:  a diabetic patient and this is the demographic information we are going after about that person.  Pertinent and clinically relevant information would be pulled up about you and on your profile.  We are only showing things that matter.  The fact that you are a 40-year woman is information the doctor already knows.  But the fact that you are a single mother, who just got divorced 3 weeks ago, is caring for an elderly parent, and has all of these other “things”, all of these “things” would influence your ability to have an insulin pump.

What makes SDOH data a must have for patient engagement and patient-centered care? (more…)

#MedMo16: finalists, winners, and what they tell us about the state of health tech

December 9, 2016 | by
[grow_thumb image=”https://telecareaware.com/wp-content/uploads/2015/11/MedStartr_red_grey_sm.jpg” thumb_width=”125″ /]Having attended two conferences in the past two weeks, and squinting to read the tea leaves in the cup, there are some trends that this Editor is picking up. They are quite different from what has been seen over the past year or two. They’ll be expanded on in articles to follow. From the top:

  • Successful companies fit into a bigger picture. Startups into early-stage companies, which were the focus at #MedMo16, are now playing the niches like genetics, patient-focused discovery, condition management and cost-effective specialized clinical innovations.
  • Anything that simplifies a process and saves money is attractive. Complex ‘big data’, analytics and ‘population health/integration’ solutions aren’t in the lead anymore because there are a lot of them and they all look alike.
  • Nothing is revolutionary. The idea that an app, device or software will ‘revolutionize healthcare as we know it’ is now recognized as absurd. (The cocktail/drinks party is ovah!) Cases must be proved first, usually on your self-funded or FFF (families, friends and fools) dime, if you want to partner with the Big Dogs.
  • Value-based care, this year’s darling, is already being seen as a vague ‘catch-all’ in a way that Triple Aim and ‘outcomes/evidence-based care’ were eventually found to be. As a meme, it’s turning out to have the life of a fruit fly.
  • It has to be easy to access, preferably on something the average patient or clinician already has or can acquire easily, like a laptop, tablet or smartphone. The idea of having to place a special purpose-built device in, let’s say, a home, is looking more and more ‘analogue’ indeed, a trend we are seeing in the traditional hub-based telehealth market and even slowly in telecare and traditional PERS.
  • Funding models are changing, with more bootstrapping, self-funding, expand you go and less emphasis on big investment and selling out fast. As funders on a NYeC DHC panel pointed out last Wednesday, don’t raise more – or less – than you need.

At #MedMo16, Crowd Challenge participants were judged by a combination of the interested MedStartr/Health 2.0 NYC community through the MedStartr funding platform, and then by a panel of judges who have leading clinical, technological, patient advocate and funding experience. In short, a group that has seen a lot over the past decade plus, has been up and down the Hype Cycle, and is down to Brass Tacks.

The innovations that bubbled up through the finalists (more…)

Patients as People: creating clinically relevant social insights (part I)

December 9, 2016 | by

Guest Editor Sarianne Gruber (@subtleimpact) reviews how one of the #MedMo16 Crowd Challenge winners, Aloha Health, has the ambitious goal of putting the ‘patient as person’ into the present healthcare model. They aim to provide and integrate into the patient record social factors and the context of everyday life, including environmental factors.

“The need to see patients as people is very real. It is an ideal that will drive healthcare transformation.”  Mandi Bishop (@MandiBPro) Founder & CEO of Aloha Health (@Aloha_Health).

Mandi Bishop prefers to be called the Chief Evangelist rather than the Chief Executive Officer.  Her new start-up, Aloha Health, launched this past July and she is making considerable traction.  I caught up with Ms. Bishop in New York at MedStartr Momentum, an equity Crowd Challenge, where she won the People’s Choice award. (Congratulations to Mandi and the Aloha Health team!)

Here is an edited transcript of our conversation.

What makes Aloha Health “unique” as a healthcare data and analytics company?

Bishop: Aloha Health was designed with a singular mission – to allow providers, care managers, and people who are participating in the patient’s care to “view” a patient as a person.  All contextual information about “you” is what makes you unique. This view of  “clinically relevant social determinants” is important because it impacts  your ability to manage your health on many levels such as your ability to follow instructions, how you  interpret information,  who you trust and how you engage. It is really important because we [providers] are all pressed for time. We are already seeing the patient revolution and hearing a lot of talk about engaging patients.  Aloha Health is providing an opportunity to see patients as people without imposing additional time. We give you specific insights to help you see your patients as people.

How do see non-clinical insights adding value to value-based care metrics?

Bishop: As our industry moves from volume to value and from fee for service to more programs like comprehensive joint replacement and bundled payment methodologies such as ACO models. These types of shared savings programs involve shared risk. When you have a capitated payment structure where you are being asked to manage the care of an entire population, including people with a set number of funds. Obviously, you have to find ways to be very effective in that care delivery. You have to understand all the things about that population, and each patient as an individual to help him or her to help themselves become healthier.  In turn, this saves money for organizations through improved health outcomes.

What types of data would be considered as the “other 95 percent”?

Bishop: The first 5 percent of the health data happens in the clinical setting.  The remaining data is what we refer to as the “other 95 percent” and is what happens at home, at work, and in the environment.  (more…)

Optum’s Utopia of proactive patient care–without telehealth

December 6, 2016 | by

[grow_thumb image=”https://telecareaware.com/wp-content/uploads/2015/10/question_mark.jpg” thumb_width=”150″ /]And we wonder why telehealth patient monitoring is floundering and telemedicine is only starting to take off? In this Editor’s reading today, up came this rather glossy, beautifully designed advertorial web page in The Atlantic sponsored by healthcare services provider/holding company Optum. It describes a proactive, highly supportive care process that starts with the diagnosis of a chronic condition (in this case developing CHF) through a ‘health scare’ handled at an urgent care versus a hospital ED, then to care at home (from a highly engaged nurse-practitioner no less) and a patient who, suitably engaged, is “responsibly managing her condition through a wellness approach” and has an improved lifestyle.

Other than an EMR (integrated between provider and urgent care–but EHR is the more current term), no other technology other than telephonic is mentioned in this rosy picture. Where’s the telehealth app that touches our patient, letting her chart her weight, breathing and general wellness, sending it to her EHR and alerting that nurse so she can truly be proactive in seeing changes in her patient’s health? Where’s the telemedicine virtual visit capability, especially if our patient’s out of breath outside of normal office hours, or there’s a blizzard and that nurse can’t visit? Here’s all the infrastructure built up for integrated care, but where’s the technology assistance and savings on home health visits and transportation for the patient?

It can’t be that Optum doesn’t know about what telehealth/telemedicine can do and the role it already plays in care? It can’t be that it doesn’t fit in the integrated care infrastructure? Or does it have to do with reimbursement? (Optum is the parent of giant insurer United Healthcare) Readers’ thoughts?

Rock Health announces its Top 50 in digital health (US)

December 6, 2016 | by

This Editor observes that digital health is at the state of maturity (so to speak) where entities assemble a Top 50 list and host a dinner to pass out awards. Rock Health, Fenwick & West, Goldman Sachs and Square 1 Bank cast a wide net from investment to startups in their just-released list. (Of course there will be a glitzy dinner, soon, at the kickoff of the JP Morgan Healthcare Conference, 9 – 12 January 2017 in San Francisco. Want an invite?)

Of great delight is an award to John Carreyrou of the Wall Street Journal as Reporter of the Year for his investigative work on Theranos. Other highlights are Validic (clinical/wellness data integrator) as Fastest Growing Company, Evolent Health for Best Performing IPO and BSX Technologies‘ LVL hydration monitor as Crowdfunding Hero (having raised $1.1 million when goal was $50,000). Rock Health website

What is increasingly curious to this Editor is that digital health companies, in nearly all cases, aren’t crossing borders and oceans. Every one seems to stick and be unique to its own country of origin, creatures of their own unique petri dish.

Also in other Rock Health news, having evolved a position as a venture fund/business support provider, they have added to their list of prominent partners kidney care and medical group operator DaVita. Rock Health release.

Over £15,000 for Dementia Dog in memory of Tynetec’s Billy and Lisa Graham (UK) (updated)

December 5, 2016 | by

Updated Tynetec has announced via Twitter that the £15,000 goal has been exceeded for Dementia Dog. Thanks to our Readers who donated on our 9 Nov article and retweets, Tynetec and all donors!

Local fundraisers in Perthshire have raised £11,000 (as of 5 Dec, £15,000) for dementia assistance dogs in memory of Billy and Lisa Graham, who while on holiday were tragically killed in the June 2015 Tunisia beach shooting. As Editor Charles wrote then, “Billy was well loved and respected in the industry, working in Scotland as Business Development Manager for Tynetec, and previously with Chubb. As such, even if readers did not know him personally, there is a high probability that they will have attended many conferences and exhibitions where he was also present.”

The beneficiary is Dementia Dog, which funds specially trained dogs to help and support people living with dementia in their activities of daily living, such as taking their medicine. Former colleagues and friends of the Grahams helped to raise the money as a permanent tribute to the couple by combining two things close to them–to help those with dementia and their love of dogs. The fundraising site is open to all and located on JustGiving, with all donations going to Alzheimer Scotland. A worthy cause indeed and a lovely way to remember the Grahams. More information and the story behind the fundraisers is in the Scottish Daily Record. Hat tip to Tynetec on Twitter; Tynetec has been a long time supporter of this publication.

The Theranos Story, ch. 28: when the SecDef nominee is on the Board of Directors

December 3, 2016 | by
[grow_thumb image=”https://telecareaware.com/wp-content/uploads/2016/12/jim_mattis.jpg” thumb_width=”150″ /]Does ‘Mad Dog’ ‘Warrior Monk’ James Mattis, General, USMC (ret.) have a blind spot when it comes to Theranos? President-Elect Donald J. Trump has selected him as the next Administration’s nominee for Secretary of Defense. A remarkable leader and, yes, scholar (check his background in various sources), but he has some ‘splaining to do, in this Editor’s opinion.

This Editor leads with this question because those who have been following the Continuing Saga (which, like the Nordics, seems never-ending) know that Theranos stuffed its Board of Directors (BOD), prior to last October, with a selection of Washington Luminaries, often of a great age: Henry Kissinger, George Shultz, Sen. Sam Nunn, Sen. Bill Frist (the only one with an MD), William Perry and Gary Roughead, a retired U.S. Navy admiral. It also reads like a roster of Hoover Institution Fellows except for Sen. Frist, who sticks to the East Coast. Another interesting point: Hoover is based at Stanford University, an institution from which Elizabeth Holmes dropped out to Follow Her Vision. Obviously, there was an accompanying Vision of Washington Pull.

Also joining the BOD as of July 2013, well before The Troubles, and shortly after his retirement, was Gen. Jim Mattis (also a Hoover Fellow, photo above). When the Washington Luminaries were shuffled off to a ‘board of counselors’ after the Wall Street Journal exposé hit in October, Gen. Mattis remained on the governing BOD. Unlike his fellow Fellows, he had actually been involved with a potential deployment of the lab testing equipment. As we previously noted, as commandant of US Central Command (CENTCOM is Middle East, North Africa and Central Asia), he advocated tests of the Theranos labs under in-theatre medicine conditions in 2012-13. Leaked emails cited by the Washington Post (in Gizmodo) and also in the Wall Street Journal indicate the opposition from the US Army Medical Research and Materiel Command at health-intensive Fort Detrick MD, which oversees medical research, based on the undeniable fact that the equipment and the tests weren’t FDA-cleared, which remained true two years later…and which Gen. Mattis tried to get around, being a good Marine. Nonetheless, the procurement of Theranos equipment was halted. DOD permitted him to join the BOD after retirement as long as he was not involved in any representations to DOD or the services. (Wikipedia bio)

Yesterday, Theranos also announced that it is dissolving (draining?) the ‘board of counselors’. They led with a BOD shuffle, with Daniel J. Warmenhoven, retired chairman of NetApp, replacing director Riley P. Bechtel, who is withdrawing for health reasons. (Warmenhoven also serves on the Bechtel board, so they are keeping an eye on the estimated $100 million they invested). Gizmodo and Inc. While effective January 1, the Theranos website has already scrubbed the counselors and updated the BOD.

However, Gen. Mattis remains a director, until such time as he actually becomes Secretary of Defense, which is not a lock for Senate approval by a long shot. First, he requires a Congressionally approved waiver demanded by the National Security Act of 1947, as he has been retired only four years (as of 2017) not the required seven. Second, his involvement with Theranos has already been questioned in the media. After all, it is a Federal Poster Child of Silicon Valley Bad Behavior: censured by CMS, under investigation by SEC and DOJ. It is a handy, easily understandable club with which to beat him bloody (sic). WSJ’s wrapup.

In this Editor’s opinion, the good General should have left in October, but certainly by April when CMS laid the sanctions down, banning Ms Holmes and Mr Balwani from running labs for two years in July. What is going on in the ‘Warrior Monk’s’ mind in sticking around? Is there anything to save? 

If the WSJ articles are paywalled, search on ‘Gen. James Mattis Has Ties to Theranos’ and ‘Recent Retirement, Theranos Ties Pose Possible Obstacles for Mattis Confirmation’.  Oh yes…see here for the 27 previous TTA chapters in this Continuing, Consistently Amazing Saga.

Telemedicine’s ‘missing link’ found? American Well adds Tyto Care remote diagnostics. (US)

December 2, 2016 | by
[grow_thumb image=”https://telecareaware.com/wp-content/uploads/2016/11/Mom_using_on_child_ear.jpg” thumb_width=”150″ /]Telemedicine leader American Well and telehealth newcomer Tyto Care announced a new partnership that (finally) pairs up remote diagnostics to the virtual doctor visit. Patients (or parents) can use the Tyto Care device before or during the online visit to take guided exams of the heart, lungs, abdomen, ears, throat, skin and temperature which is then shared with the doctor. The releases indicate that the American Well-Tyto Care combination will be introduced first to health systems and employers. The Tyto Care examination platform and clinical data are being integrated into American Well’s telehealth platform. Timing and pricing are not disclosed, but the retail price of Tyto Care’s home model is $299.  Tyto Care, American Well releases.

Tyto Care recently obtained FDA 510(k) Class II clearance for its digital stethoscope snap-on to the main device to monitor heart and lung sounds. [TTA 2 Nov] The all-in-one type device also includes attachments for a digital imaging otoscope for ear exams, a throat scope, a skin camera and thermometer swipe. A new and quite comprehensive demo video of Tyto Care on its own platform is viewable on YouTube, which includes how a doctor can review the information during a live video visit, or as a store-and-forward exam. Tyto Care is also introducing a professional version of its device and platform.

Tyto Care has also made it to the finals of The Best of Baby Tech (a/k/a The Bump) Awards, which include a new version of the awww-worthy Owlet smart sock baby monitor, the Edwin the Duck child learning tool, TempTraq’s continuous temperature monitor and the SNOO smart sleeper. They will be exhibited with 13 other finalists at CES 2017 in the Bump Pavilion at the Baby Tech Showcase 5-8 January, with winners in six categories on the 5th. #babytechces

PCHA Connected Health Conference in Washington–book soon!

December 2, 2016 | by

11-14 December, Gaylord National, National Harbor MD (Washington DC area)

Hosted by the Personal Connected Health Alliance, the Connected Health Conference was renamed in 2015 to reflect an increasingly consumer-centered, technology-enabled and collaborative approach to improving health, and builds on the success of the mHealth Summit. There are three days of programming with over 300 speakers, four tracks, a new and innovative exhibit floor, and specialty events. Each component — from keynotes, panel discussions, interactive sessions, roundtables and the dynamic exhibit floor — focuses on new research and actionable knowledge such as best practices, lessons learned and conclusive case studies.

  • Pre-conference sessions providing a deep dive into key topics
  • Four content tracks bringing diverse perspectives, sparking meaningful discussion and advancing new solutions around key issues such as behavior change, real time intervention, design, collaboration, data science, disparities, policy, interoperability, ethics, privacy and security, and more
  • Numerous opportunities for networking

Co-located at the Conference is the Global Digital Health Forum, which addresses digital health in low- and middle-income countries.

Click on the advert in the right hand sidebar or the link above to learn more. When you register, use code TELE100 for $100 off registration. TTA is a media partner of the PCHA Connected Health Conference.

What are the true costs of analogue care?

December 1, 2016 | by

With current approaches to Scotland’s social services labelled unsustainable, and health care similarly under pressure, this guest article by Tom Morton of Communicare247 argues that the potential for digital technology to address health and care needs should be realised now, rather than waiting for the limitations and costs of existing analogue solutions to become ever more apparent.

Health and care provision across the globe is under pressure to provide the best in care to a growing population, in the most efficient way possible. Different countries are responding in different ways.

In Scotland, rising demand and costs for public services mean that, “by 2020, the country’s 32 councils will have to spend an extra £700m on top of the £3.1bn per year spent now”, Accounts Commission chairman, Douglas Sinclair told BBC Scotland. He also called current approaches “not sustainable”.

Health is also facing significant financial pressures, with Audit Scotland reporting that Scottish NHS boards will have to make unprecedented savings of £492m in the current final year. Some may not be able to achieve financial balance, as all struggle to meet the needs of a growing and ageing population.

Health and care providers are looking to address these issues by delivering more person-centred services within the citizen’s home. For many this means wider use of telecare or technology enabled care (TEC) to provide remote monitoring, responsive alarms, and round-the-clock support for these individuals.

Telecare is delivering benefits; one report found that widespread, targeted use of telecare could create potential savings of between £3m to £7.8m for a typical council, equating to 7.4% to 19.4% of the total older peoples’ social care budget. Savings for the NHS have also been identified, with reductions in unnecessary hospital admissions and healthcare appointments.

So with such evidence of impact, it is disconcerting to know that only around one in seven of the over 65s have access to telecare services. Such technology could help address many of the issues affecting health and care provision, but it needs investment if it is to make its contribution.

Current analogue approaches are not fit for purpose
[grow_thumb image=”https://telecareaware.com/wp-content/uploads/2016/12/1950s-bakelite-md4.jpg” thumb_width=”125″ /]The UK needs to invest wisely. Currently most telecare systems are reliant on phone landlines – this is called ‘analogue’ telecare. But we need to invest in digital telecare if we want to maintain a society where our senior and vulnerable citizens can be cared for in an acceptable way.

The analogue delivery system is unsustainable due to increasing demands, with often tragic communication failures emerging that could be avoided. Current analogue services already report around 3% of failed call attempts between the home and response services, because they cannot communicate effectively over the new digital telephone network systems. (more…)

The Theranos Story, ch. 27: investor ‘whales’ surface in class action lawsuit news

November 30, 2016 | by
[grow_thumb image=”https://telecareaware.com/wp-content/uploads/2016/11/jacobs-well-texas-woe1.jpg” thumb_width=”150″ /]Don’t jump…you may land on one of them! In the Bottomless Well that is The Unicorn Losing Its Horn, The Transubstantiation of a $9 bn valuation to $9, to mix up a Whole Lotta Metaphors, the latest is that Certain Big Investors (‘whales’ in Vegas Lingo) and at least one minnow have lost their shirts, or maybe their sleeves and cuff links.

The first is via a class action lawsuit filed Monday against Theranos in San Francisco Federal Court by Hagens Berman Sobol Shapiro LLP, seeking to represent potentially hundreds of purchasers of Theranos shares from July 29, 2013, through October 5, 2016 .

According to the Wall Street Journal, the charges relate to “false and misleading claims about its operations and technology while soliciting money from investors.” Hagens Berman is representing Silicon Valley investment banker Robert Colman, who is the retired co-founder of Robertson Stephens & Co. (a legendary, now defunct, investment bank specializing in tech that blew up after the dot-com bust). He invested through a VC fund, Lucas Venture Group, who participated in Theranos’ Series G funding in late 2013. Lucas was invited to invest $15 million, and their principals had personal ties to Elizabeth Holmes, according to TechCrunch. The second plaintiff, Hilary Taubman-Dye, purchased Theranos shares at $19/share on SharesPost Inc., an online exchange for shares of private companies, in August 2015. Her claim is that she tried to cancel it after the Wall Street Journal exposé in October, but the purchase went through in December after Theranos, Elizabeth Holmes and an unidentified third party refused to buy back the shares as a secondary transaction. TechCrunch identified her as a “longtime technical recruiter who now works in investor relations for a TV production company” which means that her investment was likely no bag of shells for her. Their respective investments are not disclosed.

The second, according to a second article in the Journal, comes from the usual ‘sources familiar with the matter’ and papers filed by Theranos in Delaware and Arizona. These include some very atypical startup investors, such as Rupert Murdoch of News Corp. and family-controlled Cox Enterprises, at $100 million each in the 2014-15 round when shares were valued at $17/each, and an undisclosed amount by Riley Bechtel of Bechtel Group, who was later named to the board of directors. Other, more typical Silicon Valley investments date back to when Theranos was the more pedestrianly named Real Time Cures in 2004 and the shares were 15 cents each:

  • Oracle co-founder Larry Ellison
  • VCs from firms such as ATA Ventures and Draper Fisher Jurvetson. The latter’s Tim Draper and his daughter (!) have been quite critical of anyone, especially John Carreyrou of the WSJ, claiming that Ms Holmes was perhaps mistaken in her scientific and business practices. (Partner Jurvetson in reports has expressed a more ‘que será, será’ attitude.) (more…)